Navigation Links
Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and Fiscal Year 2012 Financial Results
Date:2/7/2013

JERSEY CITY, N.J., Feb. 7, 2013 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) today announced it will report fourth quarter and fiscal year 2012 financial results after the NASDAQ Global Market closes on February 28. The Company will host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss the financial results and highlights for the fourth quarter as well as provide a corporate update.

(Logo:  http://photos.prnewswire.com/prnh/20090413/LA97352LOGO)

The conference call may be accessed by dialing (877) 280-7280 for domestic callers and +1 (678) 825-8232 for international callers. Please specify to the operator that you would like to join "Optimer's Financial Results Call."  The conference call will be webcast live under the Investors section of Optimer's website at www.optimerpharma.com, where it will be archived for 30 days following the call.  

About Optimer Pharmaceuticals

Optimer Pharmaceuticals, Inc. is a global biopharmaceutical company focused on developing and commercializing innovative hospital specialty products that have a positive impact on society.  Optimer developed DIFICID® (fidaxomicin) tablets, an FDA-approved macrolide antibacterial drug for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older and is commercializing DIFICID in the US and Canada.  Optimer also received marketing authorization for fidaxomicin tablets in the European Union where its partner, Astellas Pharma Europe, is commercializing fidaxomicin under the trade name DIFICLIR™.  The Company is exploring marketing authorization in other parts of th
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Optimer Pharmaceuticals to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
2. First sales of DIFICLIR™ by Astellas Pharma Europe triggers 10 Million Euro Milestone Payment to Optimer Pharmaceuticals
3. Optimer Pharmaceuticals and Specialised Therapeutics Australia Collaborate to Commercialize Fidaxomicin for Clostridium difficile Infection in Australia and New Zealand
4. Optimer Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
5. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2012 Financial Results
6. Optimer Pharmaceuticals Appoints Stephen Newman to Its Board of Directors
7. Optimer Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Growth Conference
8. Optimer Pharmaceuticals to Present at September 2012 Investor Conferences
9. Optimer Pharmaceuticals Reports Third Quarter 2012 Financial Results
10. Optimer Pharmaceuticals to Present at November 2012 Investor Conferences
11. Optimer Pharmaceuticals to Present at 23rd Annual Oppenheimer Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... 2015 Braeburn Pharmaceuticals announced today ... focus beyond addiction and pain to include ... has acquired an implantable, six-month formulation of ... treatment of schizophrenia from Endo Pharmaceuticals. With ... to other potential applications of the implant ...
(Date:5/1/2015)... , May 1, 2015 Semler Scientific, ... assessment company that develops, manufactures and markets products that ... diseases, today reported financial results for the first quarter ... first quarter of 2015, Semler reported continued progress with ... over quarter revenue growth of 14%," said Doug ...
(Date:4/30/2015)... /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: ... on Omega-3 therapies for cardiovascular disease (CVD) and ... results for the fiscal year ended December 31, ... Canadian dollars unless otherwise stated. "Pivotal,s ... right strategic partners and additional capitalization in 2015, ...
Breaking Medicine Technology:Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 2Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 3Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments 4Semler Reports First Quarter 2015 Financial Results 2Semler Reports First Quarter 2015 Financial Results 3Semler Reports First Quarter 2015 Financial Results 4Semler Reports First Quarter 2015 Financial Results 5Pivotal Therapeutics Announces 2014 Financial Results 2Pivotal Therapeutics Announces 2014 Financial Results 3Pivotal Therapeutics Announces 2014 Financial Results 4Pivotal Therapeutics Announces 2014 Financial Results 5Pivotal Therapeutics Announces 2014 Financial Results 6
... Dec. 13, 2011 /PRNewswire-Asia/ -- Bristol-Myers Squibb Company ... Pharmaceutical Group (NYSE: SCR ), a ... companies have expanded the strategic partnership formed last year ... area. The companies agreed to co-develop BMS-795311, Bristol-Myers Squibb,s ...
...  BioMed Realty Trust, Inc. (NYSE: BMR ) ... agreement to acquire Prudential Real Estate Investors, (PREI) 80% ... a 20% interest in the properties in April 2007 ... and PREI.  The Rogers Street properties are located in ...
Cached Medicine Technology:Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Cardiovascular Compound 2Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Cardiovascular Compound 3Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Cardiovascular Compound 4Biomed Realty Trust to Acquire Remaining 80% Interest in Rogers Street Properties in Cambridge, Massachusetts for $308 Million - Increasing Ownership to 100% 2Biomed Realty Trust to Acquire Remaining 80% Interest in Rogers Street Properties in Cambridge, Massachusetts for $308 Million - Increasing Ownership to 100% 3Biomed Realty Trust to Acquire Remaining 80% Interest in Rogers Street Properties in Cambridge, Massachusetts for $308 Million - Increasing Ownership to 100% 4
(Date:5/4/2015)... California (PRWEB) May 04, 2015 For ... a brand new lubricant -- Astroglide TTC™ (Trying ... sperm motility and alter pH levels, Astroglide TTC™ is ... , According to the Centers for Disease Control, ... have trouble getting pregnant or sustaining a pregnancy, and ...
(Date:5/4/2015)... “ Food Cost Calculator ” was featured ... a look at the latest and coolest applications on the ... of AppWatch and technology expert, conducted the app review and ... manage and efficiently calculate food costs. , The restaurant industry ... the industry has an estimated 1.8 trillion dollar impact on ...
(Date:5/4/2015)... DC (PRWEB) May 04, 2015 ... has just released the first-ever congenital heart ... Cardiac Catheterization Laboratory (PCCL) accreditation. Driven by ... standards are a comprehensive review of interventional ... congenital heart disease. , “The ACE CHD ...
(Date:5/4/2015)... May 04, 2015 “St. Louis has ... “Gateway to the West,” so it is the perfect ... Program”, says Dr. Ben Litalien, Chief Development Officer for ... VetFran program and will provide veterans with a $10,000 ... is proud to have a number of Military Veterans ...
(Date:5/4/2015)... 2015 Sara Soulati, CEO of ... firm in Los Angeles associated with the field of ... of The Sara Soulati Health For Life Program (SSHFLP). ... a lifestyle modification and disease prevention program. A ... U. S. Patents and Trademarks Office and is now ...
Breaking Medicine News(10 mins):Health News:Astroglide Announces the Birth of Its New Baby: Astroglide TTC 2Health News:Astroglide Announces the Birth of Its New Baby: Astroglide TTC 3Health News:An Application to Manage a Successful Restaurant Was Featured on NewsWatch Television 2Health News:Accreditation for Cardiovascular Excellence (ACE) Publishes New Standards for Pediatric and Adult Congenital Cardiac Catheterization Laboratories 2Health News:Zerorez® Creates “Gateway” for Veterans--Announces VetFran Participation. Plans Expansion into the St. Louis Region. 2Health News:Zerorez® Creates “Gateway” for Veterans--Announces VetFran Participation. Plans Expansion into the St. Louis Region. 3Health News:CEO Sara Soulati Announces Patent-Pending Designation For The Sara Soulati Health For Life Program 2
... a fair distribution of bird flu vaccines, the World ... stockpile of vaccines// for developing countries. ,The global ... fight against avian influenza, WHO director general Margaret Chan ... ,Chan met President Susilo Bambang Yudhoyono Wednesday ...
... one million children under the age of five lose ... ,Considering the fact that these deaths are ... vaccine that addresses seven different strains of pneumococcal diseases ... ,Pneumococcal diseases, which affect the lungs, brain and the ...
... older population may soon be facing a medical care crisis ... rapidly//, say researchers at the University of Cincinnati. ... be more than 70 million people over the age of ... data collected over the last decade, the number of certified ...
... breast cancer who are treated with both chemotherapy ... patients who receive only tamoxifen//. But a combination ... ovaries from functioning—did not show any additional benefits, ... ,Survival rates improve for patients with ...
... Mediterranean diet could help protect children from respiratory allergies and ... and Spanish researchers assessed the diet and health of almost ... conditions are rare. ,Crete is the largest ... Mediterranean Sea. ,Researchers found those children reared on ...
... drugs during a recent influenza B epidemic in Japan ... the drugs//, according to a study. ,Two ... of drugs known as neuraminidase inhibitors, have been effective ... documented evidence of the emergence of oseltamivir-resistant type A ...
Cached Medicine News:Health News:Number of Students Taking Up Geriatric Medicine on the Decline 2Health News:Combining Therapies can Improve Survival for Early-stage Breast Cancer Patients 2Health News:Fruit and Vegetable Diet 'could Prevent Asthma' 2Health News:Study Suggests Some Drug Resistance to Influenza B Medications 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: